... and progressive kidney failure. Higher dietary oxidative balance scores (OBS) are associated with lower prevalence of chronic kidney disease (CKD). Methods: We investigated the association between OBS and biomarkers of inflammation using data from the Reasons for Geographic and Racial Differences in Stroke...

...Dag Eckersten; Christos Tsatsanis; Aleksander Giwercman; Laila Bruun; Mats Pihlsgård; Anders Christensson Background/Aims: Men with terminal renal failure are often infertile. Anti-müllerian hormone (AMH), a marker of Sertoli cell function, is decreased among men with chronic kidney disease (CKD...

... (TCa) (mg/dl) = TCa (mg/dl) + [4 - albumin (g/dl)]; however, it is inapplicable to advanced chronic kidney disease (CKD) patients. Methods: 1,922 samples in CKD G4 + G5 patients and 341 samples in CKD G5D patients were collected. Levels of TCa (mg/day), ionized Ca 2+ (iCa 2+ ) (mmol/l) and other...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Uremic platelets Transdermal estradiol Chronic kidney disease Bleeding Bleeding from uremic platelet...

...Alan Peralta-Ramírez; Ana Isabel Raya; Carmen Pineda; Mariano Rodríguez; Escolástico Aguilera-Tejero; Ignacio López Background/Aims: Vascular calcification (VC), a major complication in humans and animals with chronic kidney disease (CKD), is influenced by changes in acid-base balance. The purpose...

... system inhibitors (RAS-Is) on serum ADMA levels, nitric oxide (NO) synthesis and oxidative stress in normotensive patients with chronic kidney disease (CKD). Methods: This study included 23 normotensive patients with chronic glomerulonephritis and normal or mildly impaired renal function who underwent...

...Omar García-Sánchez; José Miguel López-Novoa; Francisco J. López-Hernández Background/Aims: Chronic kidney disease (CKD) is a progressive deterioration of the kidney function, which may eventually lead to renal failure and the need for dialysis or kidney transplant. Whether initiated...

...Akashi Togawa; Satoko Uyama; Seiko Takanohashi; Megumi Shimasaki; Takehiko Miyaji; Hiroyuki Endo; Yoshihide Fujigaki Background: Metabolic acidosis is known to accelerate the progression of chronic kidney disease (CKD). However, whether undetermined anions as indicated by the adjusted anion gap...

...Mohamed M. NasrAllah; Amal R. El-Shehaby; Noha A. Osman; Tarek Fayad; Amr Nassef; Mona M. Salem; Usama A.A. Sharaf El Din Background: Fibroblast growth factor-23 (FGF-23) has been linked to vascular calcification, ventricular hypertrophy and mortality in chronic kidney disease (CKD), although...

... of chronic kidney disease (CKD) determined by glomerular filtration rate (GFR) was investigated. Methods: The prevalence of ten risk factors (age ≥65 years, history of smoking, male gender, obesity, albuminuria, hypertension, hypercholesterolemia, hypo-HDL-cholesterolemia, hyperuricemia and anemia...

...Chika Amano; Takafumi Ito; Masahiro Egawa; Tomohiro Oka; Ken Hanada; Kosuke Matsui; Toru Nabika; Kazuaki Tanabe The prevalence of chronic kidney disease (CKD) as well as Alzheimer's disease (AD) increases with age. With the aging of the population in Japan, there is an increasing likelihood...

... agents, when they reported significant increases in the mean estimated glomerular filtration rate (eGFR) in diabetic chronic kidney disease (CKD) patients with an eGFR of 20-45 ml/min/1.73 m 2 of body surface area at enrollment who received the trial drug bardoxolone methyl versus placebo. Unfortunately...

... matrix Aristolochic acid nephropathy C57BL/6 mice Chronic kidney disease UKRI (UK Research and Innovation) AAN was induced in 8-week-old C57BL/6 mice by intraperitoneal injection of AAI (Sigma Aldrich, China) using various dosing regimens (table 2 ). Control animals received...

... is not well established. Use of a low dose of carperitide for preventing CIAKI remains controversial. We examined the protective effect of carperitide on CIAKI after coronary angiography with a small contrast volume in chronic kidney disease (CKD) patients with coronary artery disease. Methods: We randomly...

...Oanh H.D. Thang; Erik H. Serné; Muriel P.C. Grooteman; Yvo M. Smulders; Piet M. ter Wee; Geert-Jan Tangelder; Menso J. Nubé Background: Increasing age and advanced chronic kidney disease (CKD) are both associated with an attenuated vasodilator response of the skin microcirculation. In the present...

..., instructions or products referred to in the content or advertisements. Diabetes mellitus Chronic kidney disease Diabetic nephropathy therapy Drug therapy Novel agents EXTRA Minireview Nephron Extra 2012;2:278 282 DOI: 10.1159/000343312 Published online: October 30, 2012 © 2012 S. Karger AG, Basel...

...Maria Koukoulaki; Evangelos Papachristou; Christina Kalogeropoulou; Maria Papathanasiou; Petros Zampakis; Maria Vardoulaki; Dimitrios Alexopoulos; Dimitrios S. Goumenos Background: Cardiovascular disease (CVD) is the main cause of mortality in patients with chronic kidney disease (CKD...

...Sawako Kato; Bengt Lindholm; Peter Stenvinkel; Tomas J. Ekström; Karin Luttropp; Yukio Yuzawa; Yoshinari Yasuda; Yoshinari Tsuruta; Shoichi Maruyama Background/Aims: Inflammation is an established mortality risk factor in chronic kidney disease (CKD) patients. Although a previous report showed...

... chronic kidney disease (CKD). We hypothesize that elevated ALP could be partly explained by subclinical liver congestion related to left ventricular diastolic dysfunction. Methods: Doppler echocardiography was performed in 68 patients with advanced CKD followed up for a median of 2.1 years. Time-averaged...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Receptor for advanced glycation end products S100A12 Peripheral arterial disease Chronic kidney disease...